ACM
RNXT icon

ADAR1 Capital Management’s RenovoRx RNXT Stock Holding History

ADAR1 Capital Management’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,889
Closed -$26.2K – 253
2025
Q2 		$26.2K Sell
19,889
-459,994
-96% -$524K ﹤0.01% 197
2025
Q1 		$475K Buy
479,883
+282,633
+143% +$329K 0.09% 107
2024
Q4 		$254K Sell
197,250
-117,942
-37% -$134K 0.05% 148
2024
Q3 		$334K Sell
315,192
-40,048
-11% -$44.9K 0.05% 136
2024
Q2 		$401K Buy
+355,240
New +$436K 0.08% 110

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

ADAR1 Capital Management's RNXT Position: Q3 2025 in Review

ADAR1 Capital Management sold out of RenovoRx (RNXT) in Q3 2025, closing a stake of 19,889 shares — an estimated $26.2K sold.

ADAR1 Capital Management first reported a position in RNXT in Q2 2024 and held it in 5 quarters. The position peaked at $475K in Q1 2025. 31 funds tracked by Wall St. Rank hold RNXT as of Q3 2025.

  • ADAR1 Capital Management reported no remaining RenovoRx position as of Q3 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 19,889 RenovoRx shares in Q3 2025, an estimated $26.2K.
  • ADAR1 Capital Management first reported a position in RenovoRx in Q2 2024 and held it in 5 quarters.
  • ADAR1 Capital Management's RenovoRx position peaked at $475K in Q1 2025.
  • 31 funds tracked by Wall St. Rank held RenovoRx as of Q3 2025.

Based on ADAR1 Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.